Evidence map›Paper›PMID 42427759›Full record

ArticlebioRxiv : the preprint server for biology2026

Genetically Encoded Melanin as a Photostable Scattering Contrast for Whole-Brain Tomography.

Peilin Gu, Chong Chen, Jian Ren

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Peilin GuDepartment of Radiology, Massachusetts General Hospital, Boston, MA 02129, USA.
Chong ChenDepartment of Radiology, Massachusetts General Hospital, Boston, MA 02129, USA.
Jian RenDepartment of Radiology, Massachusetts General Hospital, Boston, MA 02129, USA.ORCID 0000-0002-0511-7473

Funding

High-throughput optical investigation into intact large-scale nervous systems for Alzheimers diseaseR00AG059946 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI REN, JIAN · 2023 to 2025
$857k
NIA NIH HHS R00 AG059946
6 · The paper itself

Abstract

Large-scale brain imaging has traditionally depended on fluorescent reporters, but challenges like photobleaching and inconsistent signals hinder quantitative analysis in intact tissues. In response, we present MelaCAST (melanin-based scattering CAST imaging), a novel genetically encoded scattering method for whole-brain visualization. Using AAV to deliver tyrosinase allows for cell-type-specific melanin synthesis, providing a stable intracellular scattering contrast across the mouse brain. Combining tissue clearing with scattering tomography, MelaCAST offers non-photobleaching, high-throughput volumetric imaging of genetically targeted cell populations in intact brains. This technique establishes melanin as a genetically encoded scattering reporter and broadens whole-organ imaging capabilities beyond traditional fluorescence methods.

Indexed as

AAVCASTHigh-throughputMelaninphotobleaching

Identifiers

PMID42427759
PMCPMC13345215

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.